Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06481007

ALgerian Cholecystectomy Outcomes and Determinants Study (AL-CODS)

Algerian Cholecystectomy Outcomes and Determinants Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of Oran 1 · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices. In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.

Detailed description

This study seeks to bridge this knowledge gap by offering detailed data on 30-day postoperative outcomes after cholecystectomy for benign gallbladder diseases in Algeria. This information is crucial for benchmarking existing practices, pinpointing areas for enhancement, and ultimately improving patient safety and surgical effectiveness.

Conditions

Timeline

Start date
2025-01-01
Primary completion
2025-07-01
Completion
2025-07-02
First posted
2024-07-01
Last updated
2024-07-01

Source: ClinicalTrials.gov record NCT06481007. Inclusion in this directory is not an endorsement.